-
Internal Validation of Type 2 Diabetes and Cardiovascular Events Incidences in the Core Obesity and Diabetes Model
Sep 9, 2025, 16:22 PM -
The Role of Body Fat in the Regulation of Male Fertility
Sep 9, 2025, 16:22 PM -
Early Systematic PICO Scenario Identification and Prioritization for EU HTA Joint Clinical Assessments
Sep 9, 2025, 16:22 PM -
Identifying Risk Factors Associated With Meningioma: A Systematic Review
Sep 9, 2025, 16:22 PM -
Simulated Treatment Comparisons in NICE Technology Appraisals: Frequency Trends and Implications
Sep 9, 2025, 16:22 PM -
Budget Impact and Clinical Outcomes of Energy- and Nutrient-Dense Formulas in Pediatric Disease-Related Malnutrition: A Middle Eastern Analysis
Sep 9, 2025, 16:22 PM -
Life Years Generated for Relapsed/Refractory Mantle Cell Lymphoma Patients Managed on CAR-T in an England NHS Setting
Sep 9, 2025, 16:22 PM -
Self-Reported Health Related Quality of Life (HRQoL) in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions
Sep 9, 2025, 16:22 PM -
Spillover Effects on Informal and Family Caregivers' Utility: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Measuring the Disease Burden and Quality of Life From the Schizophrenia Caregivers’ Perspective
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Related Costs Associated With Schizophrenia in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
The Impact of Burosumab on the Clinical and Economic Burden of X-Linked Hypophosphatemia in Adult Patients in France
Sep 9, 2025, 16:22 PM -
Premature Cancer-Related Morbidity and Mortality in Israel: Years Lived With Disability and Years of Life Lost Productivity Costs
Sep 9, 2025, 16:22 PM -
Preliminary Observational Analysis of Digital Health Platform Associated With Medical Cost Changes in Employer Population
Sep 9, 2025, 16:22 PM -
Can Estimands Support Aligned Evidence Generation for EU HTA? Reflections on Their Role in Joint Clinical Assessments, PICO Alignment, and Beyond
Sep 9, 2025, 16:22 PM -
Therapeutic Drug Monitoring and Selective Use of Glucarpidase in High-Dose Methotrexate Therapy: A Cost Analysis From the Algerian Payer Perspective
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Personalized Lifestyle Interventions in Obesity/Overweight: A Systematic Review
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Iptacopan for Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Previously Treated With C5 Inhibitor in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Clinical and Economic Burden Imposed by Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Belgium
Sep 9, 2025, 16:22 PM -
Cost of Treatment of Metastatic Non-Small Lung Cancer in Sweden, 2011-2023
Sep 9, 2025, 16:22 PM
